Sonoma Pharmaceuticals, Inc. Quarterly Other Assets, Noncurrent in USD from Q1 2011 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Sonoma Pharmaceuticals, Inc. quarterly Other Assets, Noncurrent history and growth rate from Q1 2011 to Q4 2024.
  • Sonoma Pharmaceuticals, Inc. Other Assets, Noncurrent for the quarter ending December 31, 2024 was $73K, a 6.41% decline year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 $73K -$5K -6.41% Dec 31, 2024 10-Q 2025-02-05
Q3 2024 $76K +$1K +1.33% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $61K -$16K -20.8% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $66K -$7K -9.59% Mar 31, 2024 10-Q 2025-02-05
Q4 2023 $78K -$230K -74.7% Dec 31, 2023 10-Q 2024-02-08
Q3 2023 $75K -$163K -68.5% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $77K -$35K -31.3% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $73K -$4K -5.2% Mar 31, 2023 10-K 2024-06-17
Q4 2022 $308K +$233K +311% Dec 31, 2022 10-Q 2023-02-14
Q3 2022 $238K +$162K +213% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $112K -$2K -1.75% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $77K -$35K -31.3% Mar 31, 2022 10-K 2023-06-21
Q4 2021 $75K -$40K -34.8% Dec 31, 2021 10-Q 2022-02-11
Q3 2021 $76K -$28K -26.9% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $114K +$45K +65.2% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 $112K +$48K +75% Mar 31, 2021 10-K 2022-07-13
Q4 2020 $115K +$42K +57.5% Dec 31, 2020 10-Q 2021-02-16
Q3 2020 $104K -$9K -7.97% Sep 30, 2020 10-Q 2020-11-20
Q2 2020 $69K -$54K -43.9% Jun 30, 2020 10-Q/A 2020-11-17
Q1 2020 $64K -$58K -47.5% Mar 31, 2020 10-K 2021-07-14
Q4 2019 $73K -$453K -86.1% Dec 31, 2019 10-Q 2020-02-14
Q3 2019 $113K -$417K -78.7% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 $123K -$355K -74.3% Jun 30, 2019 10-Q 2019-08-13
Q1 2019 $122K -$372K -75.3% Mar 31, 2019 10-K 2020-07-10
Q4 2018 $526K +$435K +478% Dec 31, 2018 10-Q 2019-02-14
Q3 2018 $530K +$435K +458% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 $478K +$383K +403% Jun 30, 2018 10-Q 2018-08-08
Q1 2018 $494K +$414K +518% Mar 31, 2018 10-K 2019-07-01
Q4 2017 $91K +$18K +24.7% Dec 31, 2017 10-Q 2018-02-14
Q3 2017 $95K +$40K +72.7% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 $95K +$36K +61% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 $80K +$15K +23.1% Mar 31, 2017 10-K 2018-06-26
Q4 2016 $73K +$6K +8.96% Dec 31, 2016 10-Q 2017-02-17
Q3 2016 $55K -$17K -23.6% Sep 30, 2016 10-Q 2016-11-15
Q2 2016 $59K -$20K -25.3% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 $65K -$3K -4.41% Mar 31, 2016 10-K 2017-06-28
Q4 2015 $67K -$13K -16.3% Dec 31, 2015 10-Q 2016-02-16
Q3 2015 $72K -$14K -16.3% Sep 30, 2015 10-Q 2015-11-10
Q2 2015 $79K -$36K -31.3% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 $68K -$60K -46.9% Mar 31, 2015 10-K 2016-06-21
Q4 2014 $80K -$64K -44.4% Dec 31, 2014 10-Q 2015-02-12
Q3 2014 $86K -$73K -45.9% Sep 30, 2014 10-Q 2014-11-13
Q2 2014 $115K -$54K -32% Jun 30, 2014 10-Q 2014-08-12
Q1 2014 $128K -$59K -31.6% Mar 31, 2014 10-K 2015-06-16
Q4 2013 $144K -$57K -28.4% Dec 31, 2013 10-Q 2014-02-14
Q3 2013 $159K -$56K -26% Sep 30, 2013 10-Q 2013-11-19
Q2 2013 $169K +$98K +138% Jun 30, 2013 10-Q 2013-08-14
Q1 2013 $187K +$115K +160% Mar 31, 2013 10-K 2014-06-30
Q4 2012 $201K +$77K +62.1% Dec 31, 2012 10-Q 2013-02-13
Q3 2012 $215K +$96K +80.7% Sep 30, 2012 10-Q 2012-11-08
Q2 2012 $71K +$2K +2.9% Jun 30, 2012 10-Q/A 2012-08-31
Q1 2012 $72K +$19K +35.8% Mar 31, 2012 10-K 2013-06-25
Q4 2011 $124K Dec 31, 2011 10-Q 2012-02-10
Q3 2011 $119K Sep 30, 2011 10-Q 2011-11-03
Q2 2011 $69K Jun 30, 2011 10-Q/A 2011-08-09
Q1 2011 $53K Mar 31, 2011 10-K 2012-06-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.